The potential role of GLP-1 agonists in psychiatric disorders: a paradigm shift in mental health treatment
GLP 1-based therapy, originally developed for blood sugar management, can help individuals lose weight under medical supervision
Its reducing obesity-related disease and improving long-term health. Results from an earlier retatrutide trial, TRIUMPH-1 which helped some adults lose as much as 30 percent of their starting body weight have got people talking, says Mir Ali, MD, the medical director of MemorialCare Surgical Weight Loss Center at Orange Coast Medical Center in Fountain Valley, California
When Metformin Remains a First-Line Choice Metformin remains the standard initial medication for type 2 diabetes because it is affordable, well-tolerated, has decades of safety data, and addresses insulin resistancethe root driver of many metabolic disorders
The clinical trial starting dose (1 mg/week) is already close to the community protocol (1.5 mg/week split 3x)
A Canadian supplier who stocks retatrutide domestically, maintains cold-chain storage, and ships same-day via Canada Post Xpresspost is absorbing ongoing warehousing, insurance, and logistics costs